Literature DB >> 25075711

Cognition and motivation as treatment targets in schizophrenia.

Richard S E Keefe1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25075711     DOI： 10.1001/jamapsychiatry.2014.1281

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN： 2168-622X            Impact factor:   21.596


× No keyword cloud information.
  5 in total

1.  Why are there no approved treatments for cognitive impairment in schizophrenia?

Authors:  Richard S E Keefe
Journal:  World Psychiatry       Date:  2019-06       Impact factor: 49.548

Review 2.  History of the Concept of Disconnectivity in Schizophrenia.

Authors:  Joseph T Coyle; Darrick T Balu; Matthew D Puhl; Glenn T Konopaske
Journal:  Harv Rev Psychiatry       Date:  2016 Mar-Apr       Impact factor: 3.732

3.  Screening for cognitive impairment in schizophrenia: Psychometric properties of the German version of the Screen for Cognitive Impairment in Psychiatry (SCIP-G).

Authors:  Gabriele Sachs; Iris Lasser; Scot E Purdon; Andreas Erfurth
Journal:  Schizophr Res Cogn       Date:  2021-05-12

4.  Measuring negative symptoms in patients with schizophrenia: reliability and validity of the Korean version of the Motivation and Pleasure Scale-Self-Report.

Authors:  Ji-Sun Kim; Seon-Kyeong Jang; Seon-Cheol Park; Jung-Seo Yi; Joong-Kyu Park; Jung Suk Lee; Kee-Hong Choi; Seung-Hwan Lee
Journal:  Neuropsychiatr Dis Treat       Date:  2016-05-11       Impact factor: 2.570

5.  A multicenter, randomized controlled trial of individualized occupational therapy for patients with schizophrenia in Japan.

Authors:  Takeshi Shimada; Manami Ohori; Yusuke Inagaki; Yuko Shimooka; Naoya Sugimura; Ikuyo Ishihara; Tomotaka Yoshida; Masayoshi Kobayashi
Journal:  PLoS One       Date:  2018-04-05       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.